pipette
ESEspañol

Continuous directed evolution using engineered human B cell lines

Stanley Bram, Diego J. Orea, Graeme Lindsey, Soyu Zi, Jordan Quenneville, Hui Xu, Sarah Leach, Jenna J. Guthmiller, Angad P. Mehta

Peer-reviewed journalBold claims, read criticallyReal-world use

In the authors' words

Abstract The B cells of the human immune system have evolved somatic hypermutation (SHM) mechanisms that introduce mutations at the immunoglobulin genomic loci at a significantly higher frequency than the rest of the genome thereby allowing them to evolve antibody sequences without compromising fitness due to genome-wide mutations. Inspired by these observations, here we develop a continuous directed evolution platform in human B cell lines (CODE-HB) that repurposes the SHM mechanisms to a stable, non-immunoglobulin genomic locus of the human B cell lines to continuously evolve cytosolic and surface displayed proteins with a broad mutational spectrum comprising of substitutions, deletions and insertions. Using our human B cell surface display platform and CODE-HB, we evolve neutralizing antibodies targeting avian influenza and escape variants of influenza. Given the modularity and simplicity of CODE-HB, we anticipate that this platform can be used for rapidly evolving biotechnologically relevant biomolecules directly in human cells.

Main resultThe abstract does not state a limitation.

Appeared: Sunday, November 8. Nature Communications. Peer-reviewed journal.

DOI: 10.1038/s41467-026-79127-y